---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-068730"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2023-06-07T23:59:59+00:00"
generated_at: "2026-06-14T05:39:22.732621+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents shareholders elect directors, approve say-on-pay, ratify auditor at 2023 annual meeting

## Summary
- All five director nominees elected with at least 18.6M votes for; no dissident candidates.
- Advisory approval of named executive officer compensation passed: 14.1M for, 2.8M against, 4.0M abstain.
- Ratification of WithumSmith+Brown, PC as auditor for FY 2023: 29.4M for, 268k against, 145k abstain.
- Quorum of 29.8M shares (67.8% of outstanding) represented at the meeting.

## SEC filing metadata
- accession: 0001104659-23-068730
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2023-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465923068730/0001104659-23-068730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465923068730/tm2317973d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-068730
- JSON: https://secwatch.observer/filing/0001104659-23-068730.json
- Plain text: https://secwatch.observer/filing/0001104659-23-068730.txt

## Key facts
- Shareholder Votes
  Cytosorbents Corp shareholders approved Election of five directors to serve until the Company's 2024 Annual Meeting of Stockholders, or until their respective successors shall have been duly elected and qualified at the 2023-06-06 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 1 — Election of Directors The vote with respect to the election of directors was as follows: Nominees For Against Abstain Broker Non-Votes Dr. Phillip P. Chan 20,039,568 790,050 71,592 8,925,916 Dr. Edward R. Jones 20,176,235 653,457 71,518 8,925,916 Michael Bator 18,628,159 2,200,221 72,830 8,925,916 Alan D. Sobel 20,076,869 749,935 74,406 8,925,916 Jiny Kim 20,213,793 554,746 132,671 8,925,916
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923068730/0001104659-23-068730-index.htm
- Shareholder Votes
  Cytosorbents Corp shareholders approved Ratification of the appointment of WithumSmith+Brown, PC, as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-06 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 3 — Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of WithumSmith+Brown, PC, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was as follows: For Against Abstain 29,413,721 268,190 145,215
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923068730/0001104659-23-068730-index.htm
- Shareholder Votes
  Cytosorbents Corp shareholders approved Approval, on an advisory basis, of the compensation of the Company's named executive officers, disclosed pursuant to Item 402 of Regulation S-K at the 2023-06-06 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-06
  source text: Proposal No. 2 — Approval of the Compensation of the Company’s Named Executive Officers The vote with respect to the approval of, on an advisory basis, the compensation of the Company’s named executive officers, disclosed pursuant to Item 402 of Regulation S-K was as follows : For Against Abstain Broker Non-Votes 14,146,730 2,774,611 3,979,869 8,925,916
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465923068730/0001104659-23-068730-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.